Arbutus Biopharma Corporation (ABUS) Dropped -5.82% or -0.36 To Price $5.75 On Monday


Arbutus Biopharma Corporation (ABUS) dropped -5.82% or -0.36 to $5.75. It is approximately 132139 shares traded, which is 84.21% compare to the average total volume 156917. The market cap of ABUS is $316.94 million. The year to date change is 11.93%. The 52 week price range is from $3.2 to $8.25. Price of ABUS have changed -8.27% during last week. It have changed 11.93% over last month, 16.19% over last 3 months, 4.27% over last 6 months and 67.12% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 5.54. It is -3.65% below current price. The 200-day Moving Averages for ABUS is 5.38. It is -6.43% below current price. The 52-week High is 8.25. It is 43.48% from the current price. The 52-week Low is 3.2. It is -44.35% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 4.47 on 2018-04-30. Short % to float is 1.37%. There are some statistics of ABUS. It is has market cap $316.94 million. The share outstanding is 55.17 million. The average volume is 156917. The revenue is 7.93M. The gross profit is -23051000. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -51.95%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -29.80%.


Tags:

Share this post